Zepos & Yannopoulos acted as local counsel for Diorama Investments, a private equity fund managed by DECA Investments AIFM, on the sale of a minority stake in the leading European pharmaceutical developer and manufacturer PharOS Ltd to a shareholder consortium of Viessmann Generations Group and Armira. Latham & Watkins acted as international counsel to PharOS and Diorama Investments for this transaction.
Our team has been advising Diorama on its strategic cooperation with PharOS since 2019, which following an international sale process culminated in Diorama’s exit from the company highlighting its successful track record on mid-market transactions in Greece. Pharos’ founders will retain the majority control of the company, while their new partnership will foster PharOS’ further growth and strengthen its impact on the global healthcare industry.
Our team was led by Stathis Orfanoudakis, partner, working together with Stefanos Charaktiniotis, head of M&A, and supported by Elia Bastali, associate. Elina Filippou, head of Private Clients, and Elina Belouli, senior associate, advised on specific tax aspects relating to the transaction.